Expression of human CD226 on T cells and natural killer cells and of soluble CD226 in plasma of HIV-1-infected Chinese patients

Viral Immunology

Volumn 19, Issue 3, 2006, Pages 576-581

  Ye, Xiaohui ^a   Zhang, Zining ^a   Jiang, Yongjun ^a   Han, Xiaoxu ^a   Wang, Yanan ^a   Zhang, Min ^a   Liu, Jing ^a   Geng, Wenqing ^a   Dai, Di ^a   Shi, Wanying ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD226 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; BLOOD LEVEL; BLOOD SAMPLING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MALE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT; T LYMPHOCYTE; VIRUS CELL INTERACTION;

ADOLESCENT; ADULT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHINA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; MALE; T-LYMPHOCYTES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33750951313     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.576     Document Type: Conference Paper

References (20)

1. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, Hamann D, Prins M, and Miedema F: Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003;17:1881-1888.
2. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989;243:355-361.
3. Tahara-Hanaoka S, Miyanoto A, Hara A, et al. Identification and characterization of murine DNAM-1 (CO226) and its poliovirus receptor family ligands. Biochem Biophys Res Commun 2005;329:996-1000.
4. Burns GF, Triglia T, Werkmeister JA, Begley CG, and Boyd AW: TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. J Exp Med 1985;161:1063-1078.
5. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, Kitamura T, Nicholl J, Sutherland GR, Lanier LL, and Phillips JH: DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996;4:573-581.
6. Bryceson YT, March ME, Ljunggren HG, and Long EO: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006;107:159-166,
7. Tahara-Hanaoka S, Shibuya K, Kai H, Miyamoto A, Morikawa Y, Ohkochi N, Honda SI, and Shibuya A: Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood 2006;107:1491-1496.
8. Bottino C, Castriconi R, Moretta L, and Moretta A: Cellular ligands of activating NK receptors. Trends Immunol 2005;26:221-226.
9. Castriconi R, Dondero A, Corrias MV, Lanino E, Pende D, Moretta L, Bottino C, and Moretta A: Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res 2004;64:9180-9184.
10. Centers for Disease Control and Prevention: 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS among Adolescents and Adults. MMWR Recomm Rep 1992;41(RR-17):1-19.
11. + T-Cell Determinations in Persons Infected with Human Immunodeficiency Virus (HIV). MMWR Recomm Rep 1997;46(RR-2):1-29.
12. Jia W, Liu XS, Zhu Y, et al.: Preparation and characterization of MAbs against different epitopes of CD226 (PTA1). Hybridoma 2000;19:489-494.
13. [3. Shang H, Zhang ZN, Jiang YJ, et al. Activation and co-receptor expression of T lymphocytes in HIV/AIDS patients in China. J Clin Immunol 2005;25:68-72.
14. Ning SF, Jia W, Zhang XH, et al.: Development and preliminary application of a double mAb sandwich ELISA for detecting soluble CD226. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2003;19:192-194.
15. Shibuya A, Tahara-Hanaoka S, and Shibuya K: DNAM-1 (CD226), a two-sword fencer for innate and adaptive immunity. Curr Med Chem Antiinflamm Antiallergy Agents 2005;4:53-58.
16. Chen L, Xie X, Zhang X, Jia W, Jian J, Song C, and Jin B: The expression, regulation and adhesion function of a novel CD molecule, CD226, on human endothelial cells. Life Sci 2003;73:2373-2382.
17. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, Blattenberger EA, Dubbelde CE, Stone LR, Scalzo AA, and Yokoyama WM: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001;292:934-937.
18. Grossman Z and Herberman RB: T-cell homeostasis in HIV infection is neither failing nor blind: Modified cell counts reflect an adaptive response of the host. Nat Med 1997;3:486-490.
19. + T-cell depletion in HIV disease. Nature 2001;410:974-979.
20. + T-cell depletion in HIV infection: Are we closer to understanding the cause? Nat Med 2002;8:319-323.